| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 02/05/2004 | US20040023986 Treating epilepsy, neuropathic pain, and tissue damage form ischemic events; antihypoxic agents |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | US20040023344 Method for producing an optically activ beta-amino acid |
| 02/05/2004 | US20040023060 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/05/2004 | DE10233724A1 Preparation of thiophene derivatives, used as intermediate for synthesis of e.g. Duloxetine, comprises hydrogenation of ketone compounds with enantiomer-enriched bidentate phosphorus-containing ligand |
| 02/05/2004 | DE10022829B4 p-Aminophenol-Derivate und diese Verbindungen enthaltende Haarfärbemittel p-aminophenol derivatives and compositions containing these compounds Hair dyes |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2493975A1 N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | CA2493228A1 Process for the preparation of 3-hydroxy-(2-thienyl)propanamines |
| 02/04/2004 | EP1386901A1 Method for producing an optically active beta-amino acid |
| 02/04/2004 | EP1386663A1 Microencapsulated metal catalyst |
| 02/04/2004 | EP1386605A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385505A2 Acne treatment |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1232152B1 Improved process for preparing nitrogen-substituted aminotetralins |
| 02/04/2004 | CN1137121C Process for preparation of 2-aminothiazolecarboxamide derivatives |
| 02/04/2004 | CN1137073C Coked benzene-thiophenium Co-separating process |
| 02/04/2004 | CN1136856C Use of strontium salts for production of pharmaceutical compositions intended for treatment of arthrosis |
| 02/03/2004 | US6686505 Process for producing optically active amino alcohols and intermediates therefore |
| 02/03/2004 | US6686478 Thienylsulphonylamino(thio)carbonyl compounds |
| 02/03/2004 | US6686439 Polyhydroxyalkanoate for use in culturing microorganisms |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 01/29/2004 | WO2004009669A1 Process for producing dendrimer, building block compound, and process for producing thiophene compound |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009581A1 Process for producing 2-alkyl-3-aminothiophene derivative |
| 01/29/2004 | WO2004009580A1 Novel compounds |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009086A1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019117 Anti tubercular drug: compostions and methods |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/28/2004 | EP1383758A1 Novel process for preparing 5-aminomethyl-2-thiophenecarbonitrile. hcl by one-pot reaction |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383736A2 Peptide deformylase inhibitors |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383495A1 Duloxetine for treatment of hot flashes |
| 01/28/2004 | EP1383463A2 Pharmaceutically active compounds and methods of use |
| 01/28/2004 | EP0981525B1 (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitriles as intermediates and process for the preparation thereof |
| 01/28/2004 | CN1471533A N-([1,2,4] triazoloazinyl) thiophene sulfonamide compounds as herbicides |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1471519A Amino alkyenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1136218C Process for preparing 3-(substituted phenyl)-5-(thienyl or fully)-1,2,4-triazoles and novel intermediates utilized therein |
| 01/28/2004 | CN1136213C New benzothiophene, benzofuran and indole compounds, preparation method there for and medicine composition containing them |
| 01/28/2004 | CN1136212C Thiophene nitrone compounds |
| 01/28/2004 | CN1136208C Intermediate for preparing 2-thiosubstituted carbapenems |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683211 Fungicides for crops |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683113 (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683108 Agonists of hedgehog signaling pathways and uses related thereto |
| 01/27/2004 | US6683107 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/27/2004 | US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007504A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | WO2004007477A1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 01/22/2004 | WO2004007459A2 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004006956A1 Drugs for improving the prognosis of brain injury and a method of screening the same |
| 01/22/2004 | US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion |
| 01/22/2004 | US20040014969 Such as methyl-4'-(4-((8-(acetylamino)ethyl)-2-naphthyl)oxy) butoxy)-(1,1'-biphenyl)-4-carboxylate; for treating/ preventing melatoninergic disorders |
| 01/22/2004 | US20040014801 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014777 Vision disorders |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | US20040014740 Compound containing sulfur containing ring; parasiticides |
| 01/22/2004 | US20040014672 Novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/22/2004 | US20040013974 Activation by light; forming images; holography |
| 01/22/2004 | DE10237246B3 (S)-3-Methylamino-1-(2-thienyl)-1-propanol-(-)-2,3,4,6-Di-O-isopropyliden-2-keto-L-gulonsäuresalz, Verfahren zu dessen Herstellung, dessen Verwendung sowie ein Verfahren zur Enantiomerenanreicherung von (S)-3-Methylamino-1-(2-thienyl)-1-propanol (S) -3-methylamino-1- (2-thienyl) -1-propanol - (-) - 2,3,4,6-di-O-isopropylidene-2-keto-L-gulonsäuresalz, process for its preparation , its use and a process for the enantiomeric enrichment of (S) -3-methylamino-1- (2-thienyl) -1-propanol |
| 01/22/2004 | CA2743341A1 Drugs for treating or preventing brain injury and a method of screening the same |
| 01/22/2004 | CA2492673A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 01/22/2004 | CA2490468A1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381366A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 01/21/2004 | EP1381360A1 Compounds and methods for inhibiting metap2 in mammals |